InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Rojkjaer Lisa, Directeur Médical. Officer active across 3 companies, notably Viracta Therapeutics, Inc.. Cumulatively, 10 disclosures have been recorded. Activity tracked since 11 May 2021. The latest transaction was filed on 17 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rojkjaer Lisa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
18,894 股0Common StockSEC:0000905148-26-000953:0
3,758 股@ US$34.62100.0% 占其流量Common StockSEC:0000905148-26-000677:0
19,717 股0Common StockSEC:0000905148-25-000302:0
4,127 股0Common StockSEC:0001209191-23-013866:0
4,127 股0Common StockSEC:0001209191-22-058974:0
4,127 股0Common StockSEC:0001209191-22-047951:0
4,127 股0Common StockSEC:0001209191-22-032670:0
4,127 股0Common StockSEC:0001209191-22-014441:0
8,254 股0Common StockSEC:0001209191-21-067046:0
32,689 股@ US$1.26100.0% 占其流量Common StockSEC:0001209191-21-032413:0
10 条申报中的 10 条
About Rojkjaer Lisa
Lisa Rojkjaer is the Chief Medical Officer at Viracta Therapeutics, Inc. She is responsible for the strategic direction of the company's medical initiatives, ensuring that research and development programs meet the highest standards. Lisa plays a key role in guiding clinical efforts and collaborating with research teams to develop innovative treatments. Her expertise contributes to advancing Viracta's objectives in the field of oncology therapies.
